Global and China Over The Counter (OTC) Drugs Market Insights, Forecast to 2026

Publisher Name :
Date: 15-Oct-2020
No. of pages: 128
Inquire Before Buying

Over The Counter (OTC) Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Over The Counter (OTC) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Over The Counter (OTC) Drugs market is segmented into

Analgesics

Dermatology Products

Gastrointestinal Products

Vitamins, Mineral, and Supplements (VMS)

Weight Loss/Dietary Products

Ophthalmic Products

Sleeping Aids

Others

Segment by Application, the Over The Counter (OTC) Drugs market is segmented into

Hospital Pharmacies

Retail Pharmacies

Online Pharmacy

Others

Regional and Country-level Analysis

The Over The Counter (OTC) Drugs market is analysed and market size information is provided by regions (countries).

The key regions covered in the Over The Counter (OTC) Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Over The Counter (OTC) Drugs Market Share Analysis

Over The Counter (OTC) Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Over The Counter (OTC) Drugs business, the date to enter into the Over The Counter (OTC) Drugs market, Over The Counter (OTC) Drugs product introduction, recent developments, etc.

The major vendors covered:

Bayer AG

Boehringer Ingelheim

GlaxoSmithKline PLC

Johnson & Johnson

Novartis International AG

Pfizer,Inc.

PGT healthcare

Sanofi S.A

Takeda

Global and China Over The Counter (OTC) Drugs Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Over The Counter (OTC) Drugs Product Introduction
1.2 Market Segments
1.3 Key Over The Counter (OTC) Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Over The Counter (OTC) Drugs Market Size Growth Rate by Type
1.4.2 Analgesics
1.4.3 Dermatology Products
1.4.4 Gastrointestinal Products
1.4.5 Vitamins, Mineral, and Supplements (VMS)
1.4.6 Weight Loss/Dietary Products
1.4.7 Ophthalmic Products
1.4.8 Sleeping Aids
1.4.9 Others
1.5 Market by Application
1.5.1 Global Over The Counter (OTC) Drugs Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacy
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Over The Counter (OTC) Drugs Market Size, Estimates and Forecasts
2.1.1 Global Over The Counter (OTC) Drugs Revenue 2015-2026
2.1.2 Global Over The Counter (OTC) Drugs Sales 2015-2026
2.2 Global Over The Counter (OTC) Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Over The Counter (OTC) Drugs Historical Market Size by Region (2015-2020)
2.3.1 Global Over The Counter (OTC) Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Over The Counter (OTC) Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Over The Counter (OTC) Drugs Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Over The Counter (OTC) Drugs Sales Forecast by Region (2021-2026)
2.4.2 Global Over The Counter (OTC) Drugs Revenue Forecast by Region (2021-2026)
3 Global Over The Counter (OTC) Drugs Competitor Landscape by Players
3.1 Global Top Over The Counter (OTC) Drugs Sales by Manufacturers
3.1.1 Global Over The Counter (OTC) Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Over The Counter (OTC) Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Global Over The Counter (OTC) Drugs Manufacturers by Revenue
3.2.1 Global Over The Counter (OTC) Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Over The Counter (OTC) Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Over The Counter (OTC) Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Over The Counter (OTC) Drugs Revenue in 2019
3.2.5 Global Over The Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Over The Counter (OTC) Drugs Price by Manufacturers
3.4 Global Over The Counter (OTC) Drugs Manufacturing Base Distribution, Product Types
3.4.1 Over The Counter (OTC) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Over The Counter (OTC) Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Over The Counter (OTC) Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Over The Counter (OTC) Drugs Market Size by Type (2015-2020)
4.1.1 Global Over The Counter (OTC) Drugs Sales by Type (2015-2020)
4.1.2 Global Over The Counter (OTC) Drugs Revenue by Type (2015-2020)
4.1.3 Over The Counter (OTC) Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Over The Counter (OTC) Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Over The Counter (OTC) Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Over The Counter (OTC) Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Over The Counter (OTC) Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Over The Counter (OTC) Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Over The Counter (OTC) Drugs Market Size by Application (2015-2020)
5.1.1 Global Over The Counter (OTC) Drugs Sales by Application (2015-2020)
5.1.2 Global Over The Counter (OTC) Drugs Revenue by Application (2015-2020)
5.1.3 Over The Counter (OTC) Drugs Price by Application (2015-2020)
5.2 Over The Counter (OTC) Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Over The Counter (OTC) Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Over The Counter (OTC) Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Over The Counter (OTC) Drugs Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China Over The Counter (OTC) Drugs Market Size YoY Growth 2015-2026
6.1.1 China Over The Counter (OTC) Drugs Sales YoY Growth 2015-2026
6.1.2 China Over The Counter (OTC) Drugs Revenue YoY Growth 2015-2026
6.1.3 China Over The Counter (OTC) Drugs Market Share in Global Market 2015-2026
6.2 China Over The Counter (OTC) Drugs Market Size by Players (International and Local Players)
6.2.1 China Top Over The Counter (OTC) Drugs Players by Sales (2015-2020)
6.2.2 China Top Over The Counter (OTC) Drugs Players by Revenue (2015-2020)
6.3 China Over The Counter (OTC) Drugs Historic Market Review by Type (2015-2020)
6.3.1 China Over The Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
6.3.2 China Over The Counter (OTC) Drugs Revenue Market Share by Type (2015-2020)
6.3.3 China Over The Counter (OTC) Drugs Price by Type (2015-2020)
6.4 China Over The Counter (OTC) Drugs Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Over The Counter (OTC) Drugs Sales Forecast by Type (2021-2026)
6.4.2 China Over The Counter (OTC) Drugs Revenue Forecast by Type (2021-2026)
6.4.3 China Over The Counter (OTC) Drugs Price Forecast by Type (2021-2026)
6.5 China Over The Counter (OTC) Drugs Historic Market Review by Application (2015-2020)
6.5.1 China Over The Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
6.5.2 China Over The Counter (OTC) Drugs Revenue Market Share by Application (2015-2020)
6.5.3 China Over The Counter (OTC) Drugs Price by Application (2015-2020)
6.6 China Over The Counter (OTC) Drugs Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Over The Counter (OTC) Drugs Sales Forecast by Application (2021-2026)
6.6.2 China Over The Counter (OTC) Drugs Revenue Forecast by Application (2021-2026)
6.6.3 China Over The Counter (OTC) Drugs Price Forecast by Application (2021-2026)
7 North America
7.1 North America Over The Counter (OTC) Drugs Market Size YoY Growth 2015-2026
7.2 North America Over The Counter (OTC) Drugs Market Facts & Figures by Country
7.2.1 North America Over The Counter (OTC) Drugs Sales by Country (2015-2020)
7.2.2 North America Over The Counter (OTC) Drugs Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Over The Counter (OTC) Drugs Market Size YoY Growth 2015-2026
8.2 Europe Over The Counter (OTC) Drugs Market Facts & Figures by Country
8.2.1 Europe Over The Counter (OTC) Drugs Sales by Country
8.2.2 Europe Over The Counter (OTC) Drugs Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Over The Counter (OTC) Drugs Market Size YoY Growth 2015-2026
9.2 Asia Pacific Over The Counter (OTC) Drugs Market Facts & Figures by Country
9.2.1 Asia Pacific Over The Counter (OTC) Drugs Sales by Region (2015-2020)
9.2.2 Asia Pacific Over The Counter (OTC) Drugs Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Over The Counter (OTC) Drugs Market Size YoY Growth 2015-2026
10.2 Latin America Over The Counter (OTC) Drugs Market Facts & Figures by Country
10.2.1 Latin America Over The Counter (OTC) Drugs Sales by Country
10.2.2 Latin America Over The Counter (OTC) Drugs Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Over The Counter (OTC) Drugs Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Over The Counter (OTC) Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Over The Counter (OTC) Drugs Sales by Country
11.2.2 Middle East and Africa Over The Counter (OTC) Drugs Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Bayer AG
12.1.1 Bayer AG Corporation Information
12.1.2 Bayer AG Description and Business Overview
12.1.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bayer AG Over The Counter (OTC) Drugs Products Offered
12.1.5 Bayer AG Recent Development
12.2 Boehringer Ingelheim
12.2.1 Boehringer Ingelheim Corporation Information
12.2.2 Boehringer Ingelheim Description and Business Overview
12.2.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Boehringer Ingelheim Over The Counter (OTC) Drugs Products Offered
12.2.5 Boehringer Ingelheim Recent Development
12.3 GlaxoSmithKline PLC
12.3.1 GlaxoSmithKline PLC Corporation Information
12.3.2 GlaxoSmithKline PLC Description and Business Overview
12.3.3 GlaxoSmithKline PLC Sales, Revenue and Gross Margin (2015-2020)
12.3.4 GlaxoSmithKline PLC Over The Counter (OTC) Drugs Products Offered
12.3.5 GlaxoSmithKline PLC Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Corporation Information
12.4.2 Johnson & Johnson Description and Business Overview
12.4.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Johnson & Johnson Over The Counter (OTC) Drugs Products Offered
12.4.5 Johnson & Johnson Recent Development
12.5 Novartis International AG
12.5.1 Novartis International AG Corporation Information
12.5.2 Novartis International AG Description and Business Overview
12.5.3 Novartis International AG Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Novartis International AG Over The Counter (OTC) Drugs Products Offered
12.5.5 Novartis International AG Recent Development
12.6 Pfizer,Inc.
12.6.1 Pfizer,Inc. Corporation Information
12.6.2 Pfizer,Inc. Description and Business Overview
12.6.3 Pfizer,Inc. Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Pfizer,Inc. Over The Counter (OTC) Drugs Products Offered
12.6.5 Pfizer,Inc. Recent Development
12.7 PGT healthcare
12.7.1 PGT healthcare Corporation Information
12.7.2 PGT healthcare Description and Business Overview
12.7.3 PGT healthcare Sales, Revenue and Gross Margin (2015-2020)
12.7.4 PGT healthcare Over The Counter (OTC) Drugs Products Offered
12.7.5 PGT healthcare Recent Development
12.8 Sanofi S.A
12.8.1 Sanofi S.A Corporation Information
12.8.2 Sanofi S.A Description and Business Overview
12.8.3 Sanofi S.A Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Sanofi S.A Over The Counter (OTC) Drugs Products Offered
12.8.5 Sanofi S.A Recent Development
12.9 Takeda
12.9.1 Takeda Corporation Information
12.9.2 Takeda Description and Business Overview
12.9.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Takeda Over The Counter (OTC) Drugs Products Offered
12.9.5 Takeda Recent Development
12.11 Bayer AG
12.11.1 Bayer AG Corporation Information
12.11.2 Bayer AG Description and Business Overview
12.11.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Bayer AG Over The Counter (OTC) Drugs Products Offered
12.11.5 Bayer AG Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Over The Counter (OTC) Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Over The Counter (OTC) Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Over The Counter (OTC) Drugs Market Segments
Table 2. Ranking of Global Top Over The Counter (OTC) Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Over The Counter (OTC) Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Analgesics
Table 5. Major Manufacturers of Dermatology Products
Table 6. Major Manufacturers of Gastrointestinal Products
Table 7. Major Manufacturers of Vitamins, Mineral, and Supplements (VMS)
Table 8. Major Manufacturers of Weight Loss/Dietary Products
Table 9. Major Manufacturers of Ophthalmic Products
Table 10. Major Manufacturers of Sleeping Aids
Table 11. Major Manufacturers of Others
Table 12. Global Over The Counter (OTC) Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 13. Global Over The Counter (OTC) Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 14. Global Over The Counter (OTC) Drugs Sales by Regions 2015-2020 (K MT)
Table 15. Global Over The Counter (OTC) Drugs Sales Market Share by Regions (2015-2020)
Table 16. Global Over The Counter (OTC) Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Over The Counter (OTC) Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 18. Global Over The Counter (OTC) Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 19. Global Over The Counter (OTC) Drugs Sales Share by Manufacturers (2015-2020)
Table 20. Global Over The Counter (OTC) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Over The Counter (OTC) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Over The Counter (OTC) Drugs as of 2019)
Table 22. Over The Counter (OTC) Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Over The Counter (OTC) Drugs Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Over The Counter (OTC) Drugs Price (2015-2020) (USD/MT)
Table 25. Over The Counter (OTC) Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Over The Counter (OTC) Drugs Product Type
Table 27. Date of International Manufacturers Enter into Over The Counter (OTC) Drugs Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Over The Counter (OTC) Drugs Sales by Type (2015-2020) (K MT)
Table 30. Global Over The Counter (OTC) Drugs Sales Share by Type (2015-2020)
Table 31. Global Over The Counter (OTC) Drugs Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Over The Counter (OTC) Drugs Revenue Share by Type (2015-2020)
Table 33. Over The Counter (OTC) Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 34. Global Over The Counter (OTC) Drugs Sales Share by Type (2021-2026)
Table 35. Global Over The Counter (OTC) Drugs Sales by Application (2015-2020) (K MT)
Table 36. Global Over The Counter (OTC) Drugs Sales Share by Application (2015-2020)
Table 37. Global Over The Counter (OTC) Drugs Sales Share by Application (2021-2026)
Table 38. Global Over The Counter (OTC) Drugs Sales Market Share Forecast by Application (2021-2026)
Table 39. Global Over The Counter (OTC) Drugs Revenue by Application (2015-2020) (US$ Million)
Table 40. Global Over The Counter (OTC) Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 41. China Over The Counter (OTC) Drugs Sales (K MT) of Key Companies (2015-2020)
Table 42. China Over The Counter (OTC) Drugs Sales Share by Company (2015-2020)
Table 43. China Over The Counter (OTC) Drugs Revenue (US$ Million) by Company (2015-2020)
Table 44. China Over The Counter (OTC) Drugs Sales (K MT) by Type (2015-2020)
Table 45. China Over The Counter (OTC) Drugs Sales Share by Type (2015-2020)
Table 46. China Over The Counter (OTC) Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 47. China Over The Counter (OTC) Drugs Price (K MT) by Type (2015-2020)
Table 48. China Over The Counter (OTC) Drugs Sales (K MT) by Type (2021-2026)
Table 49. China Over The Counter (OTC) Drugs Sales Share by Type (2021-2026)
Table 50. China Over The Counter (OTC) Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 51. China Over The Counter (OTC) Drugs Revenue Share by Type (2021-2026)
Table 52. China Over The Counter (OTC) Drugs Price (K MT) by Type (2021-2026)
Table 53. China Over The Counter (OTC) Drugs Sales (K MT) by Application (2015-2020)
Table 54. China Over The Counter (OTC) Drugs Sales Share by Application (2015-2020)
Table 55. China Over The Counter (OTC) Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 56. China Over The Counter (OTC) Drugs Sales (K MT) by Application (2021-2026)
Table 57. China Over The Counter (OTC) Drugs Sales Share by Application (2021-2026)
Table 58. China Over The Counter (OTC) Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 59. China Over The Counter (OTC) Drugs Revenue Share by Application (2021-2026)
Table 60. North America Over The Counter (OTC) Drugs Sales by Country (2015-2020) (K MT)
Table 61. North America Over The Counter (OTC) Drugs Sales Market Share by Country (2015-2020)
Table 62. North America Over The Counter (OTC) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 63. North America Over The Counter (OTC) Drugs Revenue Market Share by Country (2015-2020)
Table 64. Europe Over The Counter (OTC) Drugs Sales by Country (2015-2020) (K MT)
Table 65. Europe Over The Counter (OTC) Drugs Sales Market Share by Country (2015-2020)
Table 66. Europe Over The Counter (OTC) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 67. Europe Over The Counter (OTC) Drugs Revenue Market Share by Country (2015-2020)
Table 68. Asia Pacific Over The Counter (OTC) Drugs Sales by Region (2015-2020) (K MT)
Table 69. Asia Pacific Over The Counter (OTC) Drugs Sales Market Share by Region (2015-2020)
Table 70. Asia Pacific Over The Counter (OTC) Drugs Revenue by Region (2015-2020) (US$ Million)
Table 71. Asia Pacific Over The Counter (OTC) Drugs Revenue Market Share by Region (2015-2020)
Table 72. Latin America Over The Counter (OTC) Drugs Sales by Country (2015-2020) (K MT)
Table 73. Latin America Over The Counter (OTC) Drugs Sales Market Share by Country (2015-2020)
Table 74. Latin Americaa Over The Counter (OTC) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 75. Latin America Over The Counter (OTC) Drugs Revenue Market Share by Country (2015-2020)
Table 76. Middle East and Africa Over The Counter (OTC) Drugs Sales by Country (2015-2020) (K MT)
Table 77. Middle East and Africa Over The Counter (OTC) Drugs Sales Market Share by Country (2015-2020)
Table 78. Middle East and Africa Over The Counter (OTC) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 79. Middle East and Africa Over The Counter (OTC) Drugs Revenue Market Share by Country (2015-2020)
Table 80. Bayer AG Corporation Information
Table 81. Bayer AG Description and Business Overview
Table 82. Bayer AG Over The Counter (OTC) Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Bayer AG Over The Counter (OTC) Drugs Product
Table 84. Bayer AG Recent Development
Table 85. Boehringer Ingelheim Corporation Information
Table 86. Boehringer Ingelheim Description and Business Overview
Table 87. Boehringer Ingelheim Over The Counter (OTC) Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Boehringer Ingelheim Product
Table 89. Boehringer Ingelheim Recent Development
Table 90. GlaxoSmithKline PLC Corporation Information
Table 91. GlaxoSmithKline PLC Description and Business Overview
Table 92. GlaxoSmithKline PLC Over The Counter (OTC) Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. GlaxoSmithKline PLC Product
Table 94. GlaxoSmithKline PLC Recent Development
Table 95. Johnson & Johnson Corporation Information
Table 96. Johnson & Johnson Description and Business Overview
Table 97. Johnson & Johnson Over The Counter (OTC) Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Johnson & Johnson Product
Table 99. Johnson & Johnson Recent Development
Table 100. Novartis International AG Corporation Information
Table 101. Novartis International AG Description and Business Overview
Table 102. Novartis International AG Over The Counter (OTC) Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Novartis International AG Product
Table 104. Novartis International AG Recent Development
Table 105. Pfizer,Inc. Corporation Information
Table 106. Pfizer,Inc. Description and Business Overview
Table 107. Pfizer,Inc. Over The Counter (OTC) Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Pfizer,Inc. Product
Table 109. Pfizer,Inc. Recent Development
Table 110. PGT healthcare Corporation Information
Table 111. PGT healthcare Description and Business Overview
Table 112. PGT healthcare Over The Counter (OTC) Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. PGT healthcare Product
Table 114. PGT healthcare Recent Development
Table 115. Sanofi S.A Corporation Information
Table 116. Sanofi S.A Description and Business Overview
Table 117. Sanofi S.A Over The Counter (OTC) Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. Sanofi S.A Product
Table 119. Sanofi S.A Recent Development
Table 120. Takeda Corporation Information
Table 121. Takeda Description and Business Overview
Table 122. Takeda Over The Counter (OTC) Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Takeda Product
Table 124. Takeda Recent Development
Table 125. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 126. Key Challenges
Table 127. Market Risks
Table 128. Main Points Interviewed from Key Over The Counter (OTC) Drugs Players
Table 129. Over The Counter (OTC) Drugs Customers List
Table 130. Over The Counter (OTC) Drugs Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Over The Counter (OTC) Drugs Product Picture
Figure 2. Global Over The Counter (OTC) Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Analgesics Product Picture
Figure 4. Dermatology Products Product Picture
Figure 5. Gastrointestinal Products Product Picture
Figure 6. Vitamins, Mineral, and Supplements (VMS) Product Picture
Figure 7. Weight Loss/Dietary Products Product Picture
Figure 8. Ophthalmic Products Product Picture
Figure 9. Sleeping Aids Product Picture
Figure 10. Others Product Picture
Figure 11. Global Over The Counter (OTC) Drugs Sales Market Share by Application in 2020 & 2026
Figure 12. Hospital Pharmacies
Figure 13. Retail Pharmacies
Figure 14. Online Pharmacy
Figure 15. Others
Figure 16. Over The Counter (OTC) Drugs Report Years Considered
Figure 17. Global Over The Counter (OTC) Drugs Market Size 2015-2026 (US$ Million)
Figure 18. Global Over The Counter (OTC) Drugs Sales 2015-2026 (K MT)
Figure 19. Global Over The Counter (OTC) Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 20. Global Over The Counter (OTC) Drugs Sales Market Share by Region (2015-2020)
Figure 21. Global Over The Counter (OTC) Drugs Sales Market Share by Region in 2019
Figure 22. Global Over The Counter (OTC) Drugs Revenue Market Share by Region (2015-2020)
Figure 23. Global Over The Counter (OTC) Drugs Revenue Market Share by Region in 2019
Figure 24. Global Over The Counter (OTC) Drugs Sales Share by Manufacturer in 2019
Figure 25. The Top 10 and 5 Players Market Share by Over The Counter (OTC) Drugs Revenue in 2019
Figure 26. Over The Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Over The Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
Figure 28. Global Over The Counter (OTC) Drugs Sales Market Share by Type in 2019
Figure 29. Global Over The Counter (OTC) Drugs Revenue Market Share by Type (2015-2020)
Figure 30. Global Over The Counter (OTC) Drugs Revenue Market Share by Type in 2019
Figure 31. Global Over The Counter (OTC) Drugs Market Share by Price Range (2015-2020)
Figure 32. Global Over The Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
Figure 33. Global Over The Counter (OTC) Drugs Sales Market Share by Application in 2019
Figure 34. Global Over The Counter (OTC) Drugs Revenue Market Share by Application (2015-2020)
Figure 35. Global Over The Counter (OTC) Drugs Revenue Market Share by Application in 2019
Figure 36. China Over The Counter (OTC) Drugs Sales Growth Rate 2015-2026 (K MT)
Figure 37. China Over The Counter (OTC) Drugs Revenue Growth Rate 2015-2026 (US$ Million)
Figure 38. China Over The Counter (OTC) Drugs Market Share in Global Market 2015-2026
Figure 39. China 5 and 10 Largest Over The Counter (OTC) Drugs Players Market Share by Revenue in Over The Counter (OTC) Drugs in 2019
Figure 40. China Over The Counter (OTC) Drugs Revenue Share by Type (2015-2020)
Figure 41. China Over The Counter (OTC) Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 42. China Over The Counter (OTC) Drugs Revenue Share by Application (2015-2020)
Figure 43. China Over The Counter (OTC) Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 44. North America Over The Counter (OTC) Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 45. North America Over The Counter (OTC) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. North America Over The Counter (OTC) Drugs Sales Market Share by Country in 2019
Figure 47. North America Over The Counter (OTC) Drugs Revenue Market Share by Country in 2019
Figure 48. U.S. Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.S. Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Canada Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 51. Canada Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Over The Counter (OTC) Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 53. Europe Over The Counter (OTC) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 54. Europe Over The Counter (OTC) Drugs Sales Market Share by Country in 2019
Figure 55. Europe Over The Counter (OTC) Drugs Revenue Market Share by Country in 2019
Figure 56. Germany Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 57. Germany Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. France Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 59. France Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. U.K. Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 61. U.K. Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Italy Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 63. Italy Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Russia Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 65. Russia Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Asia Pacific Over The Counter (OTC) Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 67. Asia Pacific Over The Counter (OTC) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 68. Asia Pacific Over The Counter (OTC) Drugs Sales Market Share by Region in 2019
Figure 69. Asia Pacific Over The Counter (OTC) Drugs Revenue Market Share by Region in 2019
Figure 70. China Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 71. China Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Japan Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 73. Japan Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. South Korea Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 75. South Korea Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. India Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 77. India Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Australia Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 79. Australia Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Taiwan Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 81. Taiwan Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Indonesia Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 83. Indonesia Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Thailand Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 85. Thailand Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Malaysia Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 87. Malaysia Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Philippines Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 89. Philippines Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Vietnam Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 91. Vietnam Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Over The Counter (OTC) Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 93. Latin America Over The Counter (OTC) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 94. Latin America Over The Counter (OTC) Drugs Sales Market Share by Country in 2019
Figure 95. Latin America Over The Counter (OTC) Drugs Revenue Market Share by Country in 2019
Figure 96. Mexico Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 97. Mexico Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Brazil Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 99. Brazil Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Argentina Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 101. Argentina Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Middle East and Africa Over The Counter (OTC) Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 103. Middle East and Africa Over The Counter (OTC) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 104. Middle East and Africa Over The Counter (OTC) Drugs Sales Market Share by Country in 2019
Figure 105. Middle East and Africa Over The Counter (OTC) Drugs Revenue Market Share by Country in 2019
Figure 106. Turkey Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 107. Turkey Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Saudi Arabia Over The Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 109. Saudi Arabia Over The Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110
  • Global and China Consumer Healthcare Market Insights, Forecast to 2026
    Published: 26-Oct-2020        Price: US 3900 Onwards        Pages: 142
    Consumer Healthcare market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Consumer Healthcare market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Consumer Healthcare market is seg......
  • Global and United States Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size, Status and Forecast 2020-2026
    Published: 26-Oct-2020        Price: US 3900 Onwards        Pages: 99
    Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Scope and Market Size Post-Traumatic Stress Disorder (PTSD) Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Post-Traumatic Stress Disorder (PTSD) Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and foreca......
  • Global and Japan Postmenopausal Osteoporosis Drugs Market Insights, Forecast to 2026
    Published: 26-Oct-2020        Price: US 3900 Onwards        Pages: 147
    Postmenopausal Osteoporosis Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Postmenopausal Osteoporosis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Postm......
  • Global and China Plasma Therapeutics Market Size, Status and Forecast 2020-2026
    Published: 26-Oct-2020        Price: US 3900 Onwards        Pages: 98
    Global Plasma Therapeutics Scope and Market Size Plasma Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Plasma Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. Market segment by Type, the product can be split ......
  • Global and United States Physiotherapy Market Size, Status and Forecast 2020-2026
    Published: 26-Oct-2020        Price: US 3900 Onwards        Pages: 99
    Global Physiotherapy Scope and Market Size Physiotherapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Physiotherapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. Market segment by Type, the product can be split into - Equi......
  • Global and China Personal Care Products for Maternity Market Insights, Forecast to 2026
    Published: 26-Oct-2020        Price: US 3900 Onwards        Pages: 134
    Personal Care Products for Maternity market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Personal Care Products for Maternity market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the......
  • Global and Japan Oxidative Stress Assay for Pharmaceutical Market Size, Status and Forecast 2020-2026
    Published: 26-Oct-2020        Price: US 3900 Onwards        Pages: 92
    Global Oxidative Stress Assay for Pharmaceutical Scope and Market Size Oxidative Stress Assay for Pharmaceutical market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oxidative Stress Assay for Pharmaceutical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026......
  • Global and China Over-the-Counter Drug Market Size, Status and Forecast 2020-2026
    Published: 26-Oct-2020        Price: US 3900 Onwards        Pages: 96
    Global Over-the-Counter Drug Scope and Market Size Over-the-Counter Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Over-the-Counter Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. Market segment by Type, the product can be ......
  • Global and United States OSDF Excipients Market Insights, Forecast to 2026
    Published: 26-Oct-2020        Price: US 3900 Onwards        Pages: 134
    OSDF Excipients market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global OSDF Excipients market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the OSDF Excipients market is segmented into......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs